Rekvina Laboratories Ltd Share Price & Stock Analysis

Rekvina Laboratories Ltd (BSE: 526075) is a Vadodara, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹79 Cr, it ranks #3,426 by market cap among the 6,197 Indian listed companies on FinBizNet, and #19 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹72.62 (as of 16 Nov 2026), the share price is 0.0% below its 52-week high of ₹72.62 and 1513.8% above its 52-week low of ₹4.50. The share price is up 1513.8% over one year and up 104.5% over three months.

Key Metrics

Current Price₹72.62
Market Cap₹79 Cr
BSE Code526075
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E RatioNot meaningful (loss)
Return on Assets-26.07%
52-Week Range₹4.50 – ₹72.62
1-Year Price Change+1513.8%
3-Month Price Change+104.5%
Beta (1Y)0.45
HeadquartersVadodara, Gujarat
Websitewww.rekvinalaboratories.com

Shareholding and Delivery

Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Rekvina Laboratories Ltd

Rekvina Laboratories Limited engages in manufacturing and marketing pharmaceutical products in India. It offers pharmaceutical formulations. The company also provides contract research and manufacturing services. Rekvina Laboratories Limited was incorporated in 1988 and is based in Vadodara, India.

Products and Services

1. Pharmaceuticals-This segment manufactures and markets pharmaceutical formulations. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Pharmaceuticals-100%

Rekvina Laboratories Ltd vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Rekvina Laboratories Ltd₹79 Crn/m——+1513.8%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Rekvina Laboratories Ltd?

Rekvina Laboratories Ltd is trading at ₹72.62, with a market capitalisation of ₹79 Cr.

Which sector does Rekvina Laboratories Ltd belong to?

Rekvina Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What is the stock symbol of Rekvina Laboratories Ltd?

Rekvina Laboratories Ltd is listed on the BSE under the scrip code 526075.

How has Rekvina Laboratories Ltd's share price moved over the past year?

Rekvina Laboratories Ltd's share price is up 1513.8% over one year and up 104.5% over three months. Its 52-week range is ₹4.50 to ₹72.62.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.